CN Stock MarketDetailed Quotes

300294 China Resources Boya Bio-pharmaceutical Group

Watchlist
  • 32.72
  • -0.59-1.77%
Market Closed May 28 15:00 CST
16.50BMarket Cap75.22P/E (TTM)

China Resources Boya Bio-pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Product Currency:CNY
2023/FY
Stock NameRevenueRatio
Intravenous human immunoglobulin444.73M16.77%
Human serum albumin438.19M16.52%
Human fibrinogen419.02M15.80%
Fuda Pharmaceutical Distribution Business-Human Serum Albumin398.43M15.02%
Other279.15M10.53%
Fuda pharmaceutical distribution business-intravenous human immunoglobulin170.39M6.43%
Fuda pharmaceutical distribution business-other164.5M6.20%
Blood products business other149.75M5.65%
Oxytocin injection110.68M4.17%
Compound osteopeptide injection77.13M2.91%
View all
Industry Currency:CNY
2023/FY
Stock NameRevenueRatio
Blood products business1.45B54.74%
Fuda pharmaceutical distribution business757.8M28.57%
Biochemical medicine business335.11M12.64%
Diabetes drug business97.44M3.67%
Other9.94M0.37%
Region Currency:CNY
2023/FY
Stock NameRevenueRatio
South China932.28M35.15%
East China region822.03M31.00%
North China226.93M8.56%
Northwest region211.67M7.98%
Central China190.76M7.19%
Southwest area170.46M6.43%
Northeast area97.85M3.69%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg